Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1957 1
1960 2
1963 3
1965 1
1968 1
1969 10
1970 3
1971 14
1972 5
1973 6
1974 6
1975 7
1976 5
1977 4
1978 11
1979 7
1980 8
1981 4
1982 16
1983 16
1984 16
1985 17
1986 28
1987 22
1988 23
1989 33
1990 21
1991 24
1992 32
1993 34
1994 38
1995 35
1996 38
1997 37
1998 52
1999 40
2000 38
2001 37
2002 48
2003 30
2004 42
2005 47
2006 67
2007 73
2008 65
2009 86
2010 78
2011 57
2012 60
2013 65
2014 68
2015 94
2016 81
2017 91
2018 76
2019 82
2020 130
2021 132
2022 98
2023 97
2024 52

Text availability

Article attribute

Article type

Publication date

Search Results

2,204 results

Results by year

Filters applied: . Clear all
The following term was ignored: or
Page 1
Showing results for sagara or
Your search for Sanara Hor retrieved no results
Clinical inertia in asthma.
Fukuda Y, Homma T, Sagara H. Fukuda Y, et al. NPJ Prim Care Respir Med. 2023 Oct 14;33(1):34. doi: 10.1038/s41533-023-00356-5. NPJ Prim Care Respir Med. 2023. PMID: 37838773 Free PMC article. Review.
Epidemiology of asthma.
Makino S, Adachi M, Ago Y, Akiyama K, Baba M, Egashira Y, Fujimura M, Fukuda T, Furusho K, Iikura Y, Inoue H, Ito K, Iwamoto I, Kabe J, Kamikawa Y, Kawakami Y, Kihara N, Kitamura S, Kudo K, Mano K, Matsui T, Mikawa H, Miyagi S, Miyamoto T, Morita Y, Nagasaka Y, Nakagawa T, Nakajima S, Nakazawa T, Nishima S, Ohta K, Okubo T, Sakakibara H, Sano Y, Shinomiya K, Takagi K, Takahashi K, Tamura G, Tomioka H, Yoyoshima K, Tsukioka K, Ueda N, Yamakido M, Hosoi S, Sagara H; Research Group for Asthma Prevention and Management Guidelines. Makino S, et al. Int Arch Allergy Immunol. 2005;136 Suppl 1:5-13. doi: 10.1159/000085899. Int Arch Allergy Immunol. 2005. PMID: 15981800 Review. No abstract available.
Alectinib-Induced Diffuse Alveolar Hemorrhage.
Fukuda Y, Sagara H. Fukuda Y, et al. Arch Bronconeumol. 2023 Jun;59(6):396. doi: 10.1016/j.arbres.2023.03.013. Epub 2023 Mar 21. Arch Bronconeumol. 2023. PMID: 37080799 Free article. English, Spanish. No abstract available.
[Asthma and comorbidity].
Sagara H. Sagara H. Arerugi. 2015 Feb;64(2):104-9. Arerugi. 2015. PMID: 25924903 Japanese. No abstract available.
Reply to T.J.A. Dekker.
Modi S, Park H, Murthy RK, Iwata H, Tamura K, Tsurutani J, Moreno-Aspitia A, Doi T, Sagara Y, Redfern C, Krop IE, Lee C, Fujisaki Y, Sugihara M, Zhang L, Shahidi J, Takahashi S. Modi S, et al. J Clin Oncol. 2020 Oct 1;38(28):3351-3352. doi: 10.1200/JCO.20.01212. Epub 2020 Jul 13. J Clin Oncol. 2020. PMID: 32658630 No abstract available.
Redox of Viologen for Powering and Coloring.
Sagara T, Tahara H. Sagara T, et al. Chem Rec. 2021 Sep;21(9):2375-2388. doi: 10.1002/tcr.202100082. Epub 2021 May 25. Chem Rec. 2021. PMID: 34036724 Review.
Pharmacologic control of asthma.
Makino S, Adachi M, Ago Y, Akiyama K, Baba M, Egashira Y, Fujimura M, Fukuda T, Furusho K, Iikura Y, Inoue H, Ito K, Iwamoto I, Kabe J, Kamikawa Y, Kawakami Y, Kihara N, Kitamura S, Kudo K, Mano K, Matsui T, Mikawa H, Miyagi S, Miyamoto T, Morita Y, Nagasaka Y, Nakagawa T, Nakajima S, Nakazawa T, Nishima S, Ohta K, Okubo T, Sakakibara H, Sano Y, Shinomiya K, Takagi K, Takahashi K, Tamura G, Tomioka H, Yoyoshima K, Tsukioka K, Ueda N, Yamakido M, Hosoi S, Sagara H; Research Group for Asthma Prevention and Management Guidelines. Makino S, et al. Int Arch Allergy Immunol. 2005;136 Suppl 1:14-49. doi: 10.1159/000085903. Int Arch Allergy Immunol. 2005. PMID: 15981801 Review. No abstract available.
Discovery of Futibatinib: The First Covalent FGFR Kinase Inhibitor in Clinical Use.
Ito S, Otsuki S, Ohsawa H, Hirano A, Kazuno H, Yamashita S, Egami K, Shibata Y, Yamamiya I, Yamashita F, Kodama Y, Funabashi K, Kazuno H, Komori T, Suzuki S, Sootome H, Hirai H, Sagara T. Ito S, et al. ACS Med Chem Lett. 2023 Mar 10;14(4):396-404. doi: 10.1021/acsmedchemlett.3c00006. eCollection 2023 Apr 13. ACS Med Chem Lett. 2023. PMID: 37077386 Free PMC article.
[Treatment 'to be on the safe side': avoiding every risk in the case of malignancy or pre-malignancy].
Liefers GJ. Liefers GJ. Ned Tijdschr Geneeskd. 2015;159:A9517. Ned Tijdschr Geneeskd. 2015. PMID: 26507068 Dutch.
In a recent study in JAMA Surgery, Sagara et al. showed that patients with low-grade ductal carcinoma in situ who did not receive surgery had a similar prognosis compared to patients who did receive surgical treatment. ...'Overly' safe, but with little regard for treatment …
In a recent study in JAMA Surgery, Sagara et al. showed that patients with low-grade ductal carcinoma in situ who did not receive sur …
2,204 results